According to Benzinga Pro, Legend Biotech's peer group average for short interest as a percentage of float is 13.20%, which means the company has less short interest than most of its peers. Did you ...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech ...

Biopharma stock Sarepta Therapeutics Inc (NASDAQ:SRPT) is soaring today, up 20.6% at $22.17 at last glance. The biopharmaceutical company announced a strategic restructuring plan, laying off about 500 ...

Ligand Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 84.

Asian equities had a good day as Thailand, Indonesia, and Pakistan outperformed, while India posted a small loss.

Investing.com -- Maia Biotechnology Inc (NYSE: MAIA) stock surged 10% after the clinical-stage biopharmaceutical company announced the publication of promising preclinical data from its ...

Investment management company Vulcan Value Partners recently released its second-quarter 2025 investor letter. A copy of the ...

Sarepta Therapeutics Inc. is cutting more than one-third of its workforce and will add a black box warning label to its gene therapy for a fatal muscle disorder after two patient deaths raised doubts ...

Clearside Biomedical will divert all employees to a consulting status and halt research-and-development, allowing the eye-care biotechnology firm to conserve cash during a search for a deal or other ...

The favorable market reaction indicates investor relief at management’s swift measures to rectify the company's worsening ...

BNB coin price has surged following a treasury strategy announcement from Windtree Therapeutics, a Nasdaq-listed ...

Simulations Plus dipped after Q3 2025 on guidance cuts, but core software strength and long-term growth drivers remain. Find ...